Recurrence Rate and Risk Factors for the Recurrence of Ovarian Endometriosis after Laparoscopic Ovarian Cystectomy.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2021
Historique:
received: 03 10 2020
revised: 10 01 2021
accepted: 13 01 2021
entrez: 12 2 2021
pubmed: 13 2 2021
medline: 2 6 2021
Statut: epublish

Résumé

The aim of this study was to identify the recurrence rate and risk factors for the recurrence of ovarian endometriosis (OE) after laparoscopic cystectomy. This was a retrospective cross-sectional study. Subjects were OE cases who underwent laparoscopic ovarian cystectomy at Bhumibol Adulyadej Hospital (BAH). The period of this study was from January 2008 to December 2017. Ovarian histopathology and at least one-year follow-up after surgery were the prerequisite requirements. A total of 106 OE cases were included in the study. Subjects were classified into recurrence and nonrecurrence groups. It comprised of 24 and 82 cases, respectively. The mean age of the participant was 32.4 years old. The demographic characters of both groups were comparable. The recurrence rate after laparoscopic OE surgery in the present study was 22.6% (24/106). The average largest diameter of OE in the present study was 54.5 mm. Postoperative medical treatment (OR 3.15, 95% CI 1.14-8.74,

Identifiants

pubmed: 33575338
doi: 10.1155/2021/6679641
pmc: PMC7857866
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6679641

Informations de copyright

Copyright © 2021 Sornsittipong Wacharachawana et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Arch Gynecol Obstet. 2018 Apr;297(4):1043-1057
pubmed: 29344847
J Obstet Gynaecol. 2018 Apr;38(3):372-376
pubmed: 29017382
Womens Health (Lond). 2015 Aug;11(5):693-9
pubmed: 26439119
J Obstet Gynaecol Res. 2011 Jun;37(6):581-5
pubmed: 21159045
J Ovarian Res. 2019 Aug 30;12(1):79
pubmed: 31470880
Ginekol Pol. 2018;89(11):611-617
pubmed: 30508213
Facts Views Vis Obgyn. 2019 Jun;11(2):151-157
pubmed: 31824636
Facts Views Vis Obgyn. 2015;7(2):109-18
pubmed: 26177374
J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):213-219
pubmed: 24710935
Clin Obstet Gynecol. 2017 Jun;60(2):245-251
pubmed: 28288013
Minerva Med. 2014 Aug;105(4):295-301
pubmed: 24914702
Acta Obstet Gynecol Scand. 2013 Jan;92(1):8-16
pubmed: 22646295
Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:56-60
pubmed: 27240262
Hum Reprod. 2014 Mar;29(3):400-12
pubmed: 24435778
Adv Ther. 2020 May;37(5):2159-2168
pubmed: 32200536
Hum Reprod. 2006 Aug;21(8):2171-4
pubmed: 16644912

Auteurs

Sornsittipong Wacharachawana (S)

Department of Obstetrics and Gynecology, Bhumibol Adulyadej Hospital, Royal Thai Air Force, Thailand.

Paweena Phaliwong (P)

Department of Obstetrics and Gynecology, Bhumibol Adulyadej Hospital, Royal Thai Air Force, Thailand.

Sinart Prommas (S)

Department of Obstetrics and Gynecology, Bhumibol Adulyadej Hospital, Royal Thai Air Force, Thailand.

Buppa Smanchat (B)

Department of Obstetrics and Gynecology, Bhumibol Adulyadej Hospital, Royal Thai Air Force, Thailand.

Kornkarn Bhamarapravatana (K)

Department of Preclinical Science, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.

Komsun Suwannarurk (K)

Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH